Abeona Therapeutics Inc. ABEO
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies for serious genetic and rare diseases. Headquartered in Cleveland, Ohio, and founded in 1974, the company concentrates on advanced platforms such as adeno-associated virus (AAV) gene therapies and cell-b…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees226
TickerABEO
Statistics
Market Cap$317.9M
Revenue (TTM)$5.8M
Net Income$71.2M
Net Margin1223.1%
EPS$1.01
P/E5.82
P/S21.68
P/B2.17
EV/EBITDA-1.89
ROE71.0%
Dividend Yield—
Price$5.59
Data: Twelve Data · Revenue = mcap / P/S